Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.

The Globus-M and now -M2 are primarily for scientific research and technology demonstration. They show the potential for spherical tokamaks to generate hybrid fusion-fission nuclear power.

With this approval, the Catamaran is now indicated to treat the SI joint as either a stand-alone treatment or to augment a spinal fusion. "The FDA has cleared the Catamaran SI Joint Fusion System ...

Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.